Type 3 Spinal Muscular Atrophy clinical trials

Explore recruiting type 3 spinal muscular atrophy clinical trials.

Recruiting type 3 spinal muscular atrophy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Type 3 Spinal Muscular Atrophy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, randomised, double-blind, placebo-controlled, 2-way crossover study to evaluate the efficacy, safety, and tolerability of NMD670 in ambulatory adults with Type 3 spinal muscular atrophy

Netherlands, Spain, Belgium, Denmark, Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label, Multicenter, Extension Trial to Evaluate the Long-Term Safety and Efficacy of Apitegromab in Patients with Type 2 and Type 3 Spinal Muscular Atrophy Who Completed Previous Investigational Trials of Apitegromab (ONYX)

Poland, Belgium, France, Italy, Netherlands, Germany +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Type 3 Spinal Muscular Atrophy trials by city

Type 3 Spinal Muscular Atrophy in Toronto Type 3 Spinal Muscular Atrophy in Vancouver Type 3 Spinal Muscular Atrophy in Montreal Type 3 Spinal Muscular Atrophy in Calgary Type 3 Spinal Muscular Atrophy in Edmonton Type 3 Spinal Muscular Atrophy in Ottawa Type 3 Spinal Muscular Atrophy in Winnipeg Type 3 Spinal Muscular Atrophy in Quebec City Type 3 Spinal Muscular Atrophy in Hamilton Type 3 Spinal Muscular Atrophy in Kitchener Type 3 Spinal Muscular Atrophy in London Type 3 Spinal Muscular Atrophy in Halifax Type 3 Spinal Muscular Atrophy in New York Type 3 Spinal Muscular Atrophy in Los Angeles Type 3 Spinal Muscular Atrophy in Chicago Type 3 Spinal Muscular Atrophy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease